Background: Folic acid is one of the important supplements for adequate development during pregnancy. A higher intake of folic acid during pregnancy and lactation is recommended.
Methods: In prospective study the group of premature newborns (n = 52) and the type of nutrition were observed. The red blood cell (RBC) folate concentration levels were determined in the first 24 hours after delivery, before and after oral treatment with folic acid (100 µg/day). Immunochemical analysis for the determination of folate in erythrocytes was performed.
Results: In the group of premature newborns the RBC folate concentration levels after treatment were significantly increased (p < 0.0001). A dynamic increase in the concentration levels of folates in erythrocytes before and after treatment was observed, in spite of the reciprocally decreasing blood count parameters, but without any statistically significant correlation. The infant nutrition before treatment contained significantly higher amount of folic acid in fortified breast milk compared to breast milk (p = 0.04).
Conclusion: The various types of nutrition for preterm newborns contain a different amount of folic acid. It poses a question of real needs of these patients. The best way to determine the optimal whole amount of folate is to know the real levels of folate in premature newborns (Tab. 2, Fig. 5, Ref. 26). Text in PDF www.elis.sk.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.4149/bll_2015_066 | DOI Listing |
Nucl Med Biol
January 2025
State Research Center-Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency, 123182 Moscow, Russia. Electronic address:
Introduction: Folate receptors (FR) have been considered a convenient target for different radiopharmaceuticals in recent years. Multifarious Ga-labeled folate conjugates have been proposed as promising agents for the PET imaging of FR-overexpressing malignant neoplasms. In addition, radiolabeled folate-based conjugates can be effective for imaging non-tumor pathological foci characterized by a pronounced cluster of activated macrophages.
View Article and Find Full Text PDFCurr Cancer Drug Targets
January 2025
Department of Clinical Laboratory, Gongli Hospital of Shanghai Pudong New Area, Shanghai, 200135, China.
Background: Lenvatinib is an oral tyrosine kinase inhibitor that selectively inhib-its receptors involved in tumor angiogenesis and tumor growth. It is an emerging first-line treatment agent for hepatocellular carcinoma (HCC). However, there is no intravenous ad-ministration of Lenvatinib.
View Article and Find Full Text PDFBMC Glob Public Health
January 2025
Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Background: Undernutrition remains a global crisis and is a focus of Sustainable Development Goals. While there are multiple known, effective interventions, complex interactions between prevention and treatment and resource constraints can lead to difficulties in allocating funding. Simulation studies that use in silico simulation can help illuminate the interactions between interventions and provide insight into the cost-effectiveness of alternative packages of options.
View Article and Find Full Text PDFBMC Womens Health
January 2025
Global Health Nursing, Graduate School of Nursing Science, St. Luke's International University, 10-1 Akashi-cho, Chuo-ku, Tokyo, 104-0044, Japan.
Background: Preconception care is expected to prevent diseases, promote health, and improve pregnancy outcomes. Although a consensus exists on the efficacy of folic acid supplementation and preconception vaccination, evidence regarding comprehensive approaches to preconception care targeting the general population remains lacking. We aimed to identify and examine preconception care programs delivered to reproductive-aged women and men to promote behavioral change.
View Article and Find Full Text PDFAm J Obstet Gynecol MFM
January 2025
Department of Obstetrics and Gynecology, Macon and Joan Brock Virginia Health Sciences at ODU, Norfolk, VA, United States. Electronic address:
Background: Limited research exists on the association between preconception pro-inflammatory diets and adverse pregnancy outcomes, and this relationship remains poorly understood.
Objective: To investigate the association between preconception dietary inflammatory potential, as measured by the Dietary Inflammatory Index (DII), and adverse pregnancy outcomes in nulliparous individuals.
Methods: This was a secondary analysis of the data from the Nulliparous Outcomes Study: Mothers-to-be (nuMoM2b).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!